Medical News

RSS

Researchers reveal why people with allergic asthma are protected from severe COVID

The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep into lung tissue to cause severe disease and death in thousands of people in the United States in 2022 alone.

7 Apr 2022

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

A University of Georgia nanotechnology research group entered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company.

7 Apr 2022

New website offers accurate, reliable information about causes of cancer

A team led by the Zhu Family Center for Global Cancer Prevention at Harvard T.H. Chan School of Public Health and the Center for Cancer Equity and Engagement at the Dana-Farber/Harvard Cancer Center has launched Cancer FactFinder (https://cancerfactfinder.org/), a new website that provides accurate and reliable information about what does and does not cause cancer.

7 Apr 2022

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Nearly half of heart disease patients have insomnia, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology, and published in SLEEP Advances.

7 Apr 2022

Researchers assess prevalence of SARS-CoV-2 reinfections

Researchers assessed the prevalence of SARS-CoV-2 reinfections in the Province of Modena, Italy.

7 Apr 2022

Study investigates biochemical, biophysical, and immunological profile of COVID-19 respiratory secretions

A new study assessed the biophysical, immunological, and biochemical characteristics of respiratory secretions in acute SARS-CoV-2 infections.

7 Apr 2022

Axol Bioscience Raises £3.2 Million GBP (c. $4.2 million USD)

Axol Bioscience Ltd. today announced that it has raised £3.2 million GBP in the extension of its previous funding round, bringing the total raised to £7 million GBP.

From Axol Bioscience Ltd 7 Apr 2022

Evaluating the trustworthiness and characteristics of COVID-19-related trial preprints

Researchers investigated the impact and trustworthiness of trial preprints on COVID-19-related decision-making.

7 Apr 2022

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Adobe and Intel marketing leader, Marta DeBellis, joins as Chief Marketing Officer. Rapid7 go-to-market growth strategist, Stephanie Furfaro, appointed as Chief Revenue Officer.

7 Apr 2022

Study suggests blunted serological responses not responsible for COVID-19 mortality

A new study investigated serological profiling to determine the antibody responses in critically ill COVID-19 positive and negative patients.

7 Apr 2022

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

A recent study analyzed the antibody that mediated the COVID-19 vaccine-induced thrombotic thrombocytopenia.

7 Apr 2022

The dynamics of the Omicron wave in England

Researchers investigated the transmission dynamics of SARS-CoV-2 VOC Omicron in England using PCR testing and genomic sequencing data from the REACT-1 study.

7 Apr 2022

Creation of immunosuppressive environment is key to the progression of colorectal cancer development

Interactions between cells of the immune system and pre-cancerous cells are known to be important contributing factors to the initiation and progression of cancer.

7 Apr 2022

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

A new study examined whether SARS-CoV-2 infections in England varied by vaccination status, in cases with a previous COVID-19 positive test report individual, and by neighborhood socioeconomic deprivation, across the Delta and Omicron waves.

7 Apr 2022

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Researchers conducted a controlled, double-blinded Phase III trial to evaluate the efficacy of SARS-CoV-2) hyperimmune globulin in immunocompromised hospitalized COVID-19 patients.

7 Apr 2022

Study reveals a genetic overlap between childhood and adult mental health disorders

Hereditary factors are partly responsible for childhood anxiety and depression that persists into adulthood, according to University of Queensland researchers.

7 Apr 2022

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

A new study investigates the combination of two small molecules that target the host cells and reports a synergistic antiviral activity in vitro against SARS-CoV-2.

7 Apr 2022

Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients

Researchers tested the efficacy of sotrovimab in non-hospitalized patients with SARS-CoV-2 infection.

7 Apr 2022

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

A recent article presented the diverse pathogenesis of SARS-CoV-2 variants of concern in a humanized mouse model.

7 Apr 2022

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

Researchers analyzed the influence of the use of spectacles on COVID-19 risk in a community setting.

7 Apr 2022

Medical News

Researchers reveal why people with allergic asthma are protected from severe COVID

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

New website offers accurate, reliable information about causes of cancer

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Researchers assess prevalence of SARS-CoV-2 reinfections

Study investigates biochemical, biophysical, and immunological profile of COVID-19 respiratory secretions

Axol Bioscience Raises £3.2 Million GBP (c. $4.2 million USD)

Evaluating the trustworthiness and characteristics of COVID-19-related trial preprints

Insightful Science Bolsters Executive Team with Senior Sales and Marketing Expertise to Accelerate Growth Initiatives

Study suggests blunted serological responses not responsible for COVID-19 mortality

Molecular signature of highly stereotyped clonotypic anti-PF4 antibodies indicates shared pathways of antibody production in VITT patients

The dynamics of the Omicron wave in England

Creation of immunosuppressive environment is key to the progression of colorectal cancer development

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Study reveals a genetic overlap between childhood and adult mental health disorders

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News